OverviewChartNewsTraderScreen

BNP Paribas Knock-Out CHKP/  DE000PA3GK59  /

Frankfurt Zert./BNP
2024-11-07  9:21:09 AM Chg.+0.060 Bid9:30:21 AM Ask- Underlying Strike price Expiration date Option type
7.080EUR +0.85% 7.110
Bid Size: 2,250		 -
Ask Size: -		 Check Point Software... 98.2015 USD 2078-12-31 Call
Newsfile Corp 10-22 SEC Charges Four Companies With Misleading Cyber Disclosures
Newsfile Corp 10-20 T-NanoBio Therapeutics, Inc. to Present at the LD Micro Main Event XVII
TeleTrader 10-14 US Secret Service: Trump not in danger during latest incident
TeleTrader 10-13 Armed man using false passes arrested near Trump's California rally
TeleTrader 09-10 Israeli army stops UN convoy for 8 hours, UNRWA says
GlobeNewswire 09-03 Check Point Software Unveils New MSSP Portal for Partners: Vastly Simplifying Service Delivery and E...
GlobeNewswire 08-30 Carahsoft Sponsors 15th Annual Billington Cybersecurity Summit in Washington, D.C. on September 3-6...
GlobeNewswire 08-29 Anaptys Announces Participation in September Investor Conferences
GlobeNewswire 08-28 Mestag Therapeutics Awarded Significant Grant from Innovate UK’s Prestigious Cancer Therapeutics Pro...
GlobeNewswire 08-28 BioAtla to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
GlobeNewswire 08-27 Check Point Software to Acquire Cyberint to Transform Security Operations and Expand Managed Threat ...
TeleTrader 08-27 Ukrainian troops allegedly trying to enter Russia near Belgorod
GlobeNewswire 08-14 Molecular Templates, Inc. Reports Second Quarter 2024 Financial Results and Corporate Update
GlobeNewswire 08-14 Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering
GlobeNewswire 08-13 Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire 08-13 Replimune Announces First Patient Dosed in IGNYTE-3 Clinical Trial in Advanced Melanoma
GlobeNewswire 08-13 PDS Biotech Provides Business Update and Reports Second Quarter 2024 Financial Results
GlobeNewswire 08-13 Candel Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire 08-12 Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024...
GlobeNewswire 08-12 Altamira Therapeutics Announces Significant Enhancement of Immune Checkpoint Inhibition Therapy in C...
GlobeNewswire 08-12 Checkpoint Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Updates
GlobeNewswire 08-08 ALX Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 08-08 Bioatla Reports Second Quarter 2024 Financial Results and Highlights Recent Progress
GlobeNewswire 08-08 PDS Biotech Announces Abstract Accepted for Oral Presentation at 2024 ASTRO Annual Meeting
GlobeNewswire 08-08 Werewolf Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update